Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 58 medicines
Anvisa · 37 medicines
MS · 19 medicines · Historical list
AIFA · 16 medicines
ALIMS · 10 medicines
HALMED · 9 medicines
EMA · 6 medicines
SFDA · 4 medicines · Historical list
FDA · 4 medicines
HSA · 3 medicines
TFDA · 3 medicines
PHARMAC · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
302 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Pramipexole | Canada | 0.25 MG | Tablet | Marketed | Pro Doc Limitee |
| Pramipexole | Canada | 1 MG | Tablet | Marketed | Sanis Health INC |
| Pramipexole | Canada | 0.5 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Pramipexole | Canada | 1.5 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Pramipexole | Canada | 0.5 MG | Tablet | Marketed | Pro Doc Limitee |
| Pramipexole | Canada | 1 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Pramipexole | Canada | 1 MG | Tablet | Marketed | Pro Doc Limitee |
| Pramipexole | Canada | 0.25 MG | Tablet | Marketed | Sanis Health INC |
| Pramipexole | Canada | 0.25 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Pramipexole | Canada | 1.5 MG | Tablet | Marketed | Pro Doc Limitee |
| Pramipexole | Canada | 0.5 MG | Tablet | Marketed | Sanis Health INC |
| Pramipexole | Canada | 1.5 MG | Tablet | Not marketed | Sanis Health INC |
| Pramipexole | Canada | 0.25 MG | Tablet | Cancelled | Cobalt Pharmaceuticals Company |
| Pramipexole | Canada | 0.5 MG | Tablet | Cancelled | Cobalt Pharmaceuticals Company |
| Pramipexole | Canada | 1.5 MG | Tablet | Cancelled | Cobalt Pharmaceuticals Company |
| Pramipexole | Canada | 1.0 MG | Tablet | Cancelled | Cobalt Pharmaceuticals Company |
| Pramipexole Teva | European Union | Authorised | Teva Pharma B.V. | ||
| Pramipexole Dihydrochloride | United States | 0.125MG, 0.25MG, 0.5MG … | tablet | Marketed | Alembic |
| Pramipexole Dihydrochloride | United States | 0.375MG, 0.75MG, 1.5MG … | tablet, extended release | Marketed | Actavis Elizabeth |
| Act Pramipexole | Canada | 1 MG | Tablet | Marketed | Teva Canada Limited |
| Act Pramipexole | Canada | 0.25 MG | Tablet | Marketed | Teva Canada Limited |
| Act Pramipexole | Canada | 1.5 MG | Tablet | Marketed | Teva Canada Limited |
| Act Pramipexole | Canada | 0.5 MG | Tablet | Marketed | Teva Canada Limited |
| Apo-Pramipexole | Canada | 0.25 MG | Tablet | Marketed | Apotex INC |
| Apo-Pramipexole | Canada | 1.5 MG | Tablet | Marketed | Apotex INC |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
